Rhinitis
Full market focus for Chordate
As Chordate Medical reports its second quarter, it is no surprise that the focus is on the new agreement with...
Chordate strengthens its cash position for continued market establishment
Chordate Medical is in full swing with the market launch...
Chordate installs in Germany and launches in the United Arab Emirates
Chordate Medical has secured an agreement for the installation...
Chordate's treatment has an effect on allergic rhinitis
A new Italian study shows that Chordate Medicals...
Saudi market opens up to Chordate
Medical technology company Chordate Medical has recently received an order...
Market update Chordate Medical: “We are in a favorable position”
Chordate Medical's nerve stimulation treatment is currently being introduced at...
Chordate's CEO on entering new markets
How does Chordate Medical's treatment for rhinitis and...
Chordate makes progress in Italy, China and Saudi Arabia
Chordate Medical's year-end report for 2022 does not report particularly...
Issuance takes Chordate Medical further towards exit
A strong 2022 with positive study results and several...
Chordate Medical reports Q3 and carries out share issue
The medical technology company Chordate Medical has published its third...
Chordate accelerates its global market establishment
Last week, medical technology company Chordate Medical announced two...
Chordate summarizes H1 and looks towards sales growth
It has been an eventful first half of the year for...